Welcome to Markets Desk, here's what's moving the needle right now.
Cathie Wood made a decisive bet this week, putting nearly one hundred forty-six million dollars to work in Anthropic on its IPO day, then adding to the position as the Claude maker's stock slid back toward its offering price. That's a classic Wood playbook — buying the dip on a high-conviction AI name while the broader market hesitates.
Shifting to tech and the consumer side, Microsoft is pulling the plug on its To Do task management app after nearly a decade, and the sting here is that personal account holders are being left without a direct replacement. That's a meaningful disruption for the loyal user base that built workflows around it, and it signals Microsoft is continuing to consolidate its productivity suite around other platforms.
And in medical devices, Anteris Technologies reported strong one-year clinical data for its DurAVR transcatheter heart valve, with results drawn from one hundred high-risk aortic stenosis patients with small aortic annuli — precisely the population where outcomes have historically been difficult. The hemodynamic data is being watched closely by structural heart specialists and investors alike.
That's the tape. Markets Desk, signing off the floor.
